H.R. 7839 · 116th Congress
Continuing Access to In-Home IVIG Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
MatsuiSponsor13 cosponsors · 7 D, 6 R
R
Brady
BW
R
Wenstrup
EC
D
Case
DS
R
Schweikert
TC
R
Cole
JH
D
Harder
RK
D
Kelly
AS
R
Smith
GK
D
Butterfield
GH
R
Holding
SJ
D
Jackson Lee
GN
D
Napolitano
DK
D
Kilmer1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
This bill extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500.
What it does: CRS summary · Introduced in House · Jul 29, 2020
Continuing Access to In-Home IVIG Act
This bill extends the Medicare Intravenous Immune Globulin (IVIG) Demonstration for an additional two years and expands the maximum number of participating beneficiaries from 4,000 to 6,500. The program provides bundled payments for items and services that are necessary for in-home IVIG administration for certain beneficiaries with primary immune deficiency disease.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Continuing Access to In-Home IVIG Act
Latest action (Jul 29, 2020): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Jul 29, 2020
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.